Current Cancer Therapy Reviews
Title:Review of Patent Series eBook "Topics in Anti-Cancer Research, Volume 6, 2017"
Volume: 15 Issue: 1
Author(s): Alexander A. Shtil
Affiliation:
Export Options
About this article
Cite this article as:
Shtil A. Alexander, Review of Patent Series eBook "Topics in Anti-Cancer Research, Volume 6, 2017", Current Cancer Therapy Reviews 2019; 15 (1) . https://dx.doi.org/10.2174/1573394714666180621144333
DOI https://dx.doi.org/10.2174/1573394714666180621144333 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Erratum
Current Proteomics Evidences of Monomer, Dimer and Trimer of Recombinant Human Cyclophilin A
Protein & Peptide Letters Effects of Polymorphisms of the CYP450 Enzyme Genes on Estrogen Status and the Risk for Osteoporosis
Current Pharmacogenomics Biomedical Data Integration in Computational Drug Design and Bioinformatics
Current Computer-Aided Drug Design Phytochemicals and Antioxidants: An Evaluation in Understanding the Human Lifeline
Current Nutrition & Food Science In Silico Machine Learning Methods in Drug Development
Current Topics in Medicinal Chemistry FoxO Transcription Factors and Regenerative Pathways in Diabetes Mellitus
Current Neurovascular Research Meet Our Editorial Board Member
Current Stem Cell Research & Therapy Molecular Targets for Epigenetic Therapy of Cancer
Current Pharmaceutical Biotechnology Genetically Engineered Bacteriocins and their Potential as the Next Generation of Antimicrobials
Current Pharmaceutical Design Rational Targeting of the Urokinase Receptor (uPAR): Development of Antagonists and Non-Invasive Imaging Probes
Current Drug Targets MicroRNAs: A Novel Therapeutic Target for Schizophrenia
Current Pharmaceutical Design Antenatal Hypoxia and Pulmonary Vascular Function and Remodeling
Current Vascular Pharmacology Oxaliplapin and Capecitabine (XELOX) Based Chemotherapy in the Treatment of Metastatic Colorectal Cancer: The Right Choice in Elderly Patients
Anti-Cancer Agents in Medicinal Chemistry Molecular Pathology of Pancreatic Cancer: From Bench-to-Bedside Translation
Current Drug Targets The Role of Anticoagulation in Cancer Patients: Facts and Figures
Anti-Cancer Agents in Medicinal Chemistry Review of Airway Illnesses by Kytococcus and Rothia and a Look at Inhalatory Vancomycin as a Treatment Support
Recent Patents on Anti-Infective Drug Discovery Class III β -Tubulin (TUBB3): More than a Biomarker in Solid Tumors?
Current Molecular Medicine Development of Pin1 Inhibitors and their Potential as Therapeutic Agents
Current Medicinal Chemistry Editorial (Thematic Issue: Vaccines)
Recent Patents on Inflammation & Allergy Drug Discovery